Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
5(63%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
13%
Ph phase_3
1
13%
Ph not_applicable
4
50%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(1)
Other(1)

Detailed Status

Recruiting5
Not yet recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A4 (57.1%)

Trials by Status

not_yet_recruiting113%
recruiting563%
completed113%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8